Raphas Co., Ltd. (KOSDAQ:214260)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Manufacturing and Sales of Biodegradable Microneedles	27.22B	27.94B	23.64B	20.34B	17.86B
Manufacturing and Sales of Biodegradable Microneedles Growth	-2.58%	18.18%	16.22%	13.87%	-1.69%
Total	27.22B	27.94B	23.64B	20.34B	17.86B
Total Growth	-2.58%	18.18%	16.22%	13.87%	-1.69%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
United States of America	4.26B	2.80B	3.44B	4.06B	4.29B
United States of America Growth	52.16%	-18.49%	-15.25%	-5.34%	-15.79%
Republic of Korea	16.39B	18.92B	15.28B	7.55B	5.62B
Republic of Korea Growth	-13.39%	23.88%	102.26%	34.29%	-5.46%
Other	904.45M	647.77M	1.27B	2.42B	1.45B
Other Growth	39.62%	-48.94%	-47.66%	67.64%	-11.06%
Japan	5.66B	5.56B	3.66B	6.31B	6.51B
Japan Growth	1.71%	52.12%	-42.03%	-3.07%	18.19%
Total	27.22B	27.94B	23.64B	20.34B	17.86B
Total Growth	-2.58%	18.18%	16.22%	13.87%	-1.69%

Source: S&P Global Market Intelligence.